Scientific Session
Professional Development
David Leverenz, MD, MEd
Duke University
Durham, NC, United States
Disclosure(s): Pfizer: Grant/Research Support (Ongoing); Rheumatology Research Foundation: Grant/Research Support (Ongoing); UCB: Consultant (Terminated, December 31, 2022)